(FM) Oftalmología

2022

1. A Cross-Sectional Observational Study of the Relationship between Outdoor Exposure and Myopia in University Students, Measured by Conjunctival Ultraviolet Autofluorescence (CUVAF)

   Journal of Clinical Medicine, Vol. 11, Núm. 15

2. A Screening Tool for Self-Evaluation of Risk for Age-Related Macular Degeneration: Validation in a Spanish Population

   Translational Vision Science and Technology, Vol. 11, Núm. 6

3. ACE-Vitamin Index and Risk of Glaucoma: The SUN Project

   Nutrients, Vol. 14, Núm. 23

4. Carbohydrate intake and risk of glaucoma in the sun cohort

   European Journal of Ophthalmology, Vol. 32, Núm. 2, pp. 999-1008

5. Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomy

   Indian Journal of Ophthalmology, Vol. 70, Núm. 5, pp. 1626-1633

6. Clinical Characterization of Inpatients with Acute Conjunctivitis: A Retrospective Analysis by Natural Language Processing and Machine Learning

   Applied Sciences (Switzerland), Vol. 12, Núm. 23

7. Clinical characteristics of full thickness macular holes that closed without surgery

   British Journal of Ophthalmology, Vol. 106, Núm. 10, pp. 1463-1468

8. Comparative Study of Refraction between Wave Front-Based Refraction and Autorefraction without and with Cycloplegia in Children and Adolescents

   Children, Vol. 9, Núm. 1

9. Correction to: Recovery course of foveal microstructure in the nonsurgical resolution of full-thickness macular hole (Graefe's Archive for Clinical and Experimental Ophthalmology, (2022), 260, 10, (3173-3183), 10.1007/s00417-022-05672-z)

   Graefe's Archive for Clinical and Experimental Ophthalmology

10. Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes

    Clinical and Experimental Ophthalmology, Vol. 50, Núm. 3, pp. 312-324

11. Drivers of and Barriers to Adherence to Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treatment Management Plans: A Multi-National Qualitative Study

    Patient Preference and Adherence, Vol. 16, pp. 587-604

12. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

    The Lancet, Vol. 399, Núm. 10326, pp. 729-740

13. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

    The Lancet, Vol. 399, Núm. 10326, pp. 741-755

14. Encuesta sobre las preferencias quirúrgicas entre los glaucomatólogos en España

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 6, pp. 310-316

15. External Validation and Clinical Applicability of Two Optical Coherence Tomography–Based Risk Calculators for Detecting Glaucoma

    Translational Vision Science and Technology, Vol. 11, Núm. 7

16. Healthy Lifestyle Score and Incidence of Glaucoma: The Sun Project

    Nutrients, Vol. 14, Núm. 4

17. Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry

    Ophthalmology Retina, Vol. 6, Núm. 11, pp. 1044-1053

18. Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation

    Biomedicines, Vol. 10, Núm. 7

19. Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN)

    Memorias académicas de la Real Academia de Medicina y Cirugía de Sevilla: año 2022 (Real Academia de Medicina y Cirugía de Sevilla), pp. 349-354

20. Recovery course of foveal microstructure in the nonsurgical resolution of full-thickness macular hole

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 260, Núm. 10, pp. 3173-3183